Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...
SANTA CLARA, CA, UNITED STATES, December 18, 2025 /EINPresswire.com/ -- Accesso Biotech Corporation today announced new financial and strategic support from the Gates ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results